Neuropeptide Y can rescue neurons from cell death following the application of an excitotoxic insult with kainate in rat organotypic hippocampal slice cultures

Peptides

Volumn 28, Issue 2, 2007, Pages 288-294

  Xapelli, S ^a   Silva, A P ^a,b   Ferreira, R ^a   Malva, J O ^a,b  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Glutamate receptors; Neurodegeneration; Neuroprotection; NPY

Indexed keywords

KAINIC ACID; N [2 [1,2 DIHYDRO 3,5(4H) DIOXO 1,2 DIPHENYL 1,2,4 TRIAZOL 4 YL]ETHYL] N2 [[1 [2 [4 [5,11 DIHYDRO 6(6H) OXODIBENZ[B,E]AZEPIN 11 YL] 1 PIPERAZINYL] 2 OXOETHYL]CYCLOPENTYL]ACETYL]ARGININAMIDE; NALPHA (DIPHENYLACETYL) N (4 HYDROXYBENZYL) DEXTRO ARGININAMIDE; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR ANTAGONIST; NEUROPEPTIDE Y1 RECEPTOR; NEUROPEPTIDE Y2 RECEPTOR; PROPIDIUM IODIDE;

ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; DENTATE GYRUS; EXCITOTOXICITY; GRANULAR CELL; HIPPOCAMPUS; HORMONE ACTION; NERVE CELL NECROSIS; NEUROENDOCRINOLOGY; NEUROPROTECTION; NEUROTOXICITY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT;

ANIMALS; CELL DEATH; HIPPOCAMPUS; KAINIC ACID; NEURONS; NEUROPEPTIDE Y; RATS; RATS, WISTAR;

RATTUS;

EID: 33846629106     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2006.09.031     Document Type: Article

References (47)

1. Araujo I.M., Xapelli S., Gil J.M., Mohapel P., Petersen A., Pinheiro P.S., et al. Proteolysis of NR2B by calpain in the hippocampus of epileptic rats. Neuroreport 16 4 (2005) 393-396
2. Barros L.F., Hermosilla T., and Castro J. Necrotic volume increase and the early physiology of necrosis. Comp Biochem Physiol A Mol Integr Physiol 130 3 (2001) 401-409
3. Benmaamar R., Pham L., Marescaux C., Pedrazzini T., and Depaulis A. Induced down-regulation of neuropeptide Y-Y1 receptors delays initiation of kindling. Eur J Neurosci 18 4 (2003) 768-774
4. Berridge M.J., Lipp P., and Bootman M.D. The versatility and universality of calcium signalling. Nat Rev Mol Cell Biol 1 1 (2000) 11-21
5. Bhatia M. Apoptosis versus necrosis in acute pancreatitis. Am J Physiol Gastrointest Liver Physiol 286 2 (2004) G189-G196
6. Bijak M., and Neuropeptide Y. suppresses epileptiform activity in rat frontal cortex and hippocampus in vitro via different NPY receptor subtypes. Neurosci Lett 268 3 (1999) 115-118
7. Buja L.M., Eigenbrodt M.L., and Eigenbrodt E.H. Apoptosis and necrosis. Basic types and mechanisms of cell death. Arch Pathol Lab Med 117 12 (1993) 1208-1214
8. Colmers W.F., and El Bahh B. Neuropeptide Y and epilepsy. Epilepsy Curr 3 2 (2003) 53-58
9. Colmers W.F., Lukowiak K., and Pittman Q.J. Presynaptic action of neuropeptide Y in area CA1 of the rat hippocampal slice. J Physiol 383 (1987) 285-299
10. El Bahh B., Balosso S., Hamilton T., Herzog H., Beck-Sickinger A.G., Sperk G., et al. The anti-epileptic actions of neuropeptide Y in the hippocampus are mediated by Y2 and not Y5 receptors. Eur J Neurosci 22 6 (2005) 1417-1430
11. Ferri K.F., and Kroemer G. Organelle-specific initiation of cell death pathways. Nat Cell Biol 3 11 (2001) E255-E263
12. Fujikawa D.G., Shinmei S.S., and Cai B. Kainic acid-induced seizures produce necrotic, not apoptotic, neurons with internucleosomal DNA cleavage: implications for programmed cell death mechanisms. Neuroscience 98 1 (2000) 41-53
13. Gariboldi M., Conti M., Cavaleri D., Samanin R., and Vezzani A. Anticonvulsant properties of BIBP3226, a non-peptide selective antagonist at neuropeptide Y Y1 receptors. Eur J Neurosci 10 2 (1998) 757-759
14. Greber S., Schwarzer C., and Sperk G. Neuropeptide Y inhibits potassium-stimulated glutamate release through Y2 receptors in rat hippocampal slices in vitro. Br J Pharmacol 113 3 (1994) 737-740
15. Herzog H., Hort Y.J., Ball H.J., Hayes G., Shine J., and Selbie L.A. Cloned human neuropeptide Y receptor couples to two different second messenger systems. Proc Natl Acad Sci USA 89 13 (1992) 5794-5798
16. Hokfelt T., Broberger C., Zhang X., Diez M., Kopp J., Xu Z., et al. Neuropeptide Y: some viewpoints on a multifaceted peptide in the normal and diseased nervous system. Brain Res Brain Res Rev 26 2-3 (1998) 154-166
17. Hsu S.S., Newell D.W., Tucker A., Malouf A.T., and Winn H.R. Adenosinergic modulation of CA1 neuronal tolerance to glucose deprivation in organotypic hippocampal cultures. Neurosci Lett 178 2 (1994) 189-192
18. Jacques D., Dumont Y., Fournier A., and Quirion R. Characterization of neuropeptide Y receptor subtypes in the normal human brain, including the hypothalamus. Neuroscience 79 1 (1997) 129-148
19. Klapstein G.J., and Colmers W.F. 4-Aminopyridine and low Ca2+ differentiate presynaptic inhibition mediated by neuropeptide Y, baclofen and 2-chloroadenosine in rat hippocampal CA1 in vitro. Br J Pharmacol 105 2 (1992) 470-474
20. Klapstein G.J., and Colmers W.F. Neuropeptide Y suppresses epileptiform activity in rat hippocampus in vitro. J Neurophysiol 78 3 (1997) 1651-1661
21. Kristensen B.W., Noraberg J., Jakobsen B., Gramsbergen J.B., Ebert B., and Zimmer J. Excitotoxic effects of non-NMDA receptor agonists in organotypic corticostriatal slice cultures. Brain Res 841 1-2 (1999) 143-159
22. Kristensen B.W., Noraberg J., and Zimmer J. Comparison of excitotoxic profiles of ATPA, AMPA, KA and NMDA in organotypic hippocampal slice cultures. Brain Res 917 1 (2001) 21-44
23. Kroemer G., and Reed J.C. Mitochondrial control of cell death. Nat Med 6 5 (2000) 513-519
24. Larhammar D., Blomqvist A.G., Yee F., Jazin E., Yoo H., and Wahlested C. Cloning and functional expression of a human neuropeptide Y/peptide YY receptor of the Y1 type. J Biol Chem 267 16 (1992) 10935-10938
25. Lundell I., Berglund M.M., Starback P., Salaneck E., Gehlert D.R., and Larhammar D. Cloning and characterization of a novel neuropeptide Y receptor subtype in the zebrafish. DNA Cell Biol 16 11 (1997) 1357-1363
26. Majno G., and Joris I. Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol 146 1 (1995) 3-15
27. Malhi H., Gores G.J., and Lemasters J.J. Apoptosis and necrosis in the liver: a tale of two deaths?. Hepatology 43 2 Suppl 1 (2006) S31-S44
28. McQuiston A.R., and Colmers W.F. Neuropeptide Y2 receptors inhibit the frequency of spontaneous but not miniature EPSCs in CA3 pyramidal cells of rat hippocampus. J Neurophysiol 76 5 (1996) 3159-3168
29. Noraberg J., Kristensen B.W., and Zimmer J. Markers for neuronal degeneration in organotypic slice cultures. Brain Res Brain Res Protoc 3 3 (1999) 278-290
30. Padanilam B.J. Cell death induced by acute renal injury: a perspective on the contributions of apoptosis and necrosis. Am J Physiol Renal Physiol 284 4 (2003) F608-F627
31. Paredes M.F., Greenwood J., and Baraban S.C. Neuropeptide Y modulates a G protein-coupled inwardly rectifying potassium current in the mouse hippocampus. Neurosci Lett 340 1 (2003) 9-12
32. Pozzo Miller L.D., Mahanty N.K., Connor J.A., and Landis D.M. Spontaneous pyramidal cell death in organotypic slice cultures from rat hippocampus is prevented by glutamate receptor antagonists. Neuroscience 63 2 (1994) 471-487
33. Qian J., Colmers W.F., and Saggau P. Inhibition of synaptic transmission by neuropeptide Y in rat hippocampal area CA1: modulation of presynaptic Ca2+ entry. J Neurosci 17 21 (1997) 8169-8177
34. Rego A.C., and Oliveira C.R. Mitochondrial dysfunction and reactive oxygen species in excitotoxicity and apoptosis: implications for the pathogenesis of neurodegenerative diseases. Neurochem Res 28 10 (2003) 1563-1574
35. Scaffidi P., Misteli T., and Bianchi M.E. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418 6894 (2002) 191-195
36. Silva A.P., Carvalho A.P., Carvalho C.M., and Malva J.O. Modulation of intracellular calcium changes and glutamate release by neuropeptide Y1 and Y2 receptors in the rat hippocampus: differential effects in CA1, CA3 and dentate gyrus. J Neurochem 79 2 (2001) 286-296
37. Silva A.P., Carvalho A.P., Carvalho C.M., and Malva J.O. Functional interaction between neuropeptide Y receptors and modulation of calcium channels in the rat hippocampus. Neuropharmacology 44 2 (2003) 282-292
38. Silva A.P., Cavadas C., and Grouzmann E. Neuropeptide Y and its receptors as potential therapeutic drug targets. Clin Chim Acta 326 1-2 (2002) 3-25
39. Silva A.P., Pinheiro P.S., Carvalho A.P., Carvalho C.M., Jakobsen B., Zimmer J., et al. Activation of neuropeptide Y receptors is neuroprotective against excitotoxicity in organotypic hippocampal slice cultures. FASEB J 17 9 (2003) 1118-1120
40. Silva A.P., Xapelli S., Grouzmann E., and Cavadas C. The putative neuroprotective role of neuropeptide Y in the central nervous system. Curr Drug Targets CNS Neurol Disord 4 4 (2005) 331-347
41. Stoppini L., Buchs P.A., and Muller D. A simple method for organotypic cultures of nervous tissue. J Neurosci Methods 37 2 (1991) 173-182
42. Thiriet N., Deng X., Solinas M., Ladenheim B., Curtis W., Goldberg S.R., et al. Neuropeptide Y protects against methamphetamine-induced neuronal apoptosis in the mouse striatum. J Neurosci 25 22 (2005) 5273-5279
43. Tu B., Timofeeva O., Jiao Y., and Nadler J.V. Spontaneous release of neuropeptide Y tonically inhibits recurrent mossy fiber synaptic transmission in epileptic brain. J Neurosci 25 7 (2005) 1718-1729
44. Vezzani A., Michalkiewicz M., Michalkiewicz T., Moneta D., Ravizza T., Richichi C., et al. Seizure susceptibility and epileptogenesis are decreased in transgenic rats overexpressing neuropeptide Y. Neuroscience 110 2 (2002) 237-243
45. Vezzani A., Sperk G., and Colmers W.F. Neuropeptide Y: emerging evidence for a functional role in seizure modulation. Trends Neurosci 22 1 (1999) 25-30
46. Vornov J.J., Tasker R.C., and Coyle J.T. Direct observation of the agonist-specific regional vulnerability to glutamate, NMDA, and kainate neurotoxicity in organotypic hippocampal cultures. Exp Neurol 114 1 (1991) 11-22
47. Wettstein J.G., Earley B., and Junien J.L. Central nervous system pharmacology of neuropeptide Y. Pharmacol Ther 65 3 (1995) 397-414